Latest Breaking News On - Sol gel technologies - Page 3 : comparemela.com

Sol-Gel Technologies Ltd : Sol-Gel s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve Cream

Sol-Gel Technologies Ltd : Sol-Gel s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve Cream
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesGilad mamlokDennis riedlMori arkinExchange commissionArcutis biotherapeutics incCompany annual report on formPadagis israel pharmaceuticals ltdUs district courtDrug administrationGel technologies ltdGel technologiesAbbreviated new drug applicationRoflumilast creamPadagis roflumilast cream

Padagis Israel Pharmaceuticals Submits First-to-File ANDA for Generic Version of Roflumilast

The application for generic roflumilast cream, 0.3%, for plaque psoriasis may end up entitling Padagis to 180 days of market exclusivity.

New jerseyUnited statesMori arkinPadagis israel pharmaceuticals ltdDrug administrationUs district courtGel technologies ltdArcutis biotherapeutics incSol gel technologiesPadagis israel pharmaceuticalsAbbreviated new drug applicationRoflumilast creamPress releaseSol gel16 years

Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

An ongoing phase 3 clinical trial of SGT-610 for Gorlin Syndrome with the first patient screened; Results are expected by the end of 2025 Sol-Gel .

United kingdomUnited statesGilad mamlokCompany annual report on formGel technologies ltdZinsight technologyDrug administrationEuropean medical associationPellepharm incExchange commissionSearchlight pharma incGorlin syndromeGel technologiesOrphan drugNorth americaSearchlight pharma

Sol-Gel Technologies Ltd : Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

Sol-Gel Technologies Ltd : Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGilad mamlokStefan klotterZinsight technologyGel technologies ltdDrug administrationCompany annual report on formSearchlight pharma incPellepharm incExchange commissionEuropean medical associationGorlin syndromeGel technologiesOrphan drugNorth america

2024-03-13 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd

(2024-03-13 | NDAQ:SLGL) Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

United statesUnited kingdomGilad mamlokSearchlight pharma incExchange commissionCompany closecurlyquoteZinsight technologyPellepharm incDrug administrationCompany annual report on formEuropean medical associationGel technologies ltdGorlin syndromeGel technologiesOrphan drugNorth america